UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Completed
Unique ID issued by UMIN UMIN000015477
Receipt No. R000017478
Scientific Title A study of the effect of the self-care support program created by nurses in order to enhance diet satisfaction for chemotherapy patients with breast cancer who suffer from taste alteration
Date of disclosure of the study information 2014/10/21
Last modified on 2019/06/02

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title A study of the effect of the self-care support program created by nurses in order to enhance diet satisfaction for chemotherapy patients with breast cancer who suffer from taste alteration
Acronym A study of the effect of the self-care support program created by nurses in order to enhance diet satisfaction for chemotherapy patients with breast cancer who suffer from taste alteration
Scientific Title A study of the effect of the self-care support program created by nurses in order to enhance diet satisfaction for chemotherapy patients with breast cancer who suffer from taste alteration
Scientific Title:Acronym A study of the effect of the self-care support program created by nurses in order to enhance diet satisfaction for chemotherapy patients with breast cancer who suffer from taste alteration
Region
Japan

Condition
Condition Breast Cancer
Classification by specialty
Breast surgery Nursing
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 Examination of the effect of the intervention for diet satisfaction for taste alteration associated with the chemotherapy
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes The satisfaction level of the diet by the taste alteration
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Open -no one is blinded
Control Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Educational,Counseling,Training
Type of intervention
Behavior,custom
Interventions/Control_1 The support by the nurse using the brochure about the taste alteration
Interventions/Control_2 Usually support care by the nurse
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Female
Key inclusion criteria 1.The women who were diagnosed as breast cancer newly.
2.20 years of age or over.
3.The patients who receive chemotherapy ( anthracyclines and taxanes)before or after operation.
4.Eastern Cooperative Oncology Group (ECOG) performance status 0 to 1.
5.The patients who do not have taste alteration and oral complication or dysphagia.
6.The patients who agree with the study and do not have communication disorder.
Key exclusion criteria 1.The patients stage 4 with advanced breast cancer or the patients recurrent with breast cancer.
2.The patients who received chemotherapy previously because of cancer treatment.
3.The patients who received radiotherapy to oral cavity or salivary gland previously.
4.The patients who had operation to oral cavity previously.
5.The patients who take a medicine which contains zinc currently or previously because of taste alteration.
6.The patients with serious renal disease(more than serum Cr 2.0mg/dL), or receive dialysis.
7.The patients with serious liver disease.
8.The patients with hepatic disorder, mental disorder, an oral cavity malignant tumor and the diabetes.
9.The patients who have already taken a supplement which contains zinc or a medicine which contains zinc.
10.Patients who are excluded by the doctor&#39;s judgment.
Target sample size 150

Research contact person
Name of lead principal investigator
1st name Kazuaki
Middle name
Last name Tanabe
Organization Hiroshima University Graduate School of Biomedical & Health Sciences
Division name Department of Health Care for Adults
Zip code 734-8553
Address 1-2-3 Kasumi, Minamiku-ku, Hiroshima City, Hiroshima prefecture
TEL 082-257-5383
Email ktanae2@hiroshima-u.ac.jp

Public contact
Name of contact person
1st name Sanae
Middle name
Last name Asano
Organization Hiroshima University Graduate School of Biomedical & Health Sciences
Division name Department of Health Care for Adults
Zip code 734-8553
Address 1-2-3 Kasumi, Minamiku-ku, Hiroshima City, Hiroshima prefecture
TEL 082-257-5383
Homepage URL
Email asano-sanae@hiroshima-u.ac.jp

Sponsor
Institute Hiroshima University Graduate School of Biomedical & Health Sciences
Institute
Department

Funding Source
Organization YAMAJI FUMIKO NURSING RESERACH FUND
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Hiroshima Univercity Hospital
Address 1-2-3 Kasumi, Minamiku-ku, Hiroshima City, Hiroshima prefecture
Tel 082-257-5907
Email kasumi-kenkyu@office.hiroshima-u.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2014 Year 10 Month 21 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled 88
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2014 Year 09 Month 17 Day
Date of IRB
Anticipated trial start date
2014 Year 10 Month 24 Day
Last follow-up date
2018 Year 12 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2014 Year 10 Month 20 Day
Last modified on
2019 Year 06 Month 02 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000017478

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.